Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cigna Corp (NY:CI)

269.86 -2.13 (-0.78%)
Streaming Delayed Price Updated: 3:41 PM EST, Nov 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cigna Corp

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
36 37 Next >
News headline image
Walgreens Boots Alliance: Value or Value Trap?
Walgreens Boots Alliance issued a mixed report that shows growth across all segments and improved cash flow to help sustain the massive dividend 
Via MarketBeat
News headline image
Looking Into Cigna Group's Recent Short Interest ↗
 
Via Benzinga
News headline image
Pharmacy Retailer Giant Walgreens Ropes In Former Cigna Executive As CEO ↗
Walgreens Boots Alliance, Inc (NASDAQ: WBA) has appointed Tim Wentworth as its new  
Via Benzinga
News headline image
Scott Integrated Pain Management Offers Innovative Ketamine Treatment for CRPS Pain
A leading healthcare provider specializing in pain management, is proud to announce the addition of innovative ketamine treatment for Complex Regional Pain Syndrome (CRPS) pain. 
Via Newsworthy
NJ Ketamine Therapy For Mental Health & Addiction: Insurance Coverage Announced
Via Press Release Distribution Service
News headline image
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,900 Today ↗
 
Via Benzinga
News headline image
The question on everyone's mind: Will THE CIGNA GROUP breakout? ↗
The question on everyone's mind: Will THE CIGNA GROUP breakout? 
Via Chartmill
News headline image
NYSE:CI may be ready to breakout. ↗
THE CIGNA GROUP (NYSE:CI) Reveals Intriguing Technical Aspects. Here's What You Need to Know. 
Via Chartmill
News headline image
Pharmacy Retailer Giant Walgreens Considers Former Cigna Exec For CEO Role ↗
Walgreens Boots Alliance Inc. (NASDAQ: WBA) is reportedly considering appointing Tim Wentworth, a former executive at Cigna Group (NYSE: CI), as its next CEO amid a search for leadership 
Via Benzinga
News headline image
5 Stocks, 5 ETFs Make Moves After Friday Release Of Fed's Preferred Inflation Data ↗
 
Via Benzinga
Topics ETFs Economy
News headline image
Some Economics Of Pharmacy Benefit Managers ↗
It is a common belief, that if you could just “cut out the middleman” and “pass the savings along to consumers,” everyone would be better off. Pharmacy benefit managers are quintessential middlemen. 
Via Talk Markets
News headline image
Looking Into Cigna Group's Recent Short Interest ↗
 
Via Benzinga
News headline image
THE CIGNA GROUP (NYSE:CI) showing some interesting technicals. Here's why. ↗
THE CIGNA GROUP ( NYSE:CI ) has a good technical rating of 7 out of 10 and could possibly break out. 
Via Chartmill
News headline image
$100 Invested In Cigna Group 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
(CI) - Analyzing Cigna Group's Short Interest ↗
 
Via Benzinga
News headline image
Here's How Much $100 Invested In Cigna Group 10 Years Ago Would Be Worth Today ↗
 
Via Benzinga
Are You a Medicare Rookie? Pros Can Help You Find Right Plan
Via StatePoint Media
News headline image
The Sweet Spot: 3 GARP Stocks You Can’t Afford to Overlook ↗
These three GARP stocks are no-brainer bets offering growth and attractive valuations. Snap them up before they climb higher! 
Via InvestorPlace
News headline image
Medicare Insurance Market to See Huge Growth : Cigna, Aetna, Walmart
Stay up-to-date with Medicare Insurance Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Virginia Medicare Insurance Agency Has Unbiased Experts To Assist With Plan Choices
Via Get News
News headline image
Price Over Earnings Overview: Cigna Group ↗
 
Via Benzinga
This Fall, Older Adults Should Protect Their Health
Via StatePoint Media
News headline image
5 Dividend Growth Stocks With A Ratings And Very Little Debt ↗
With interest rates getting higher, it’s hard to find good stocks to invest in, especially dividend-growth stocks that have very little debt. 
Via Talk Markets
News headline image
CVS And Cigna Charge $6,000 For $55 Generics, How Do We Fix This? ↗
Health insurers dramatically mark up prices of generics and pharmacies are in on the scheme. 
Via Talk Markets
News headline image
Scott Integrated Pain Management Elevates Pain Management Services with Groundbreaking CRPS Ketamine Treatment
Scott Integrated Pain Management, a leading healthcare provider specializing in pain management, is pleased to announce the introduction of its cutting-edge CRPS Ketamine treatment for patients... 
Via Newsworthy
News headline image
The 3 Best Safe Stocks to Buy Now: September 2023 ↗
Buying safe stocks despite the market looking healthy is a wise investment decision because there are still signs a recession could occur. 
Via InvestorPlace
Topics Economy
News headline image
Online Medical Insurance Market May See a Big Move : Allstate, Progressive, Centene
Stay up-to-date with Online Medical Insurance Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
News headline image
2 Underappreciated Dividend Stocks to Buy in September and Hold Forever ↗
After falling significantly in recent weeks, these excellent dividend stocks look like screaming buys. 
Via The Motley Fool
HPS/PayMedix Establishes Advisory Board, Names Al Martino First Member
--News Direct-- 
Via News Direct
News headline image
2 Healthcare Stocks That Could Help Make You a Fortune ↗
These companies did well for shareholders over the last 10 years and have the potential to keep the growth going. 
Via The Motley Fool
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
36 37 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.